Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors

September 9, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search